• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COPD and cardiovascular diseases: now is the time for action!

作者信息

Leitao Filho Fernando Sergio, Sin Don D

机构信息

Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.

Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Thorax. 2018 Sep;73(9):799-800. doi: 10.1136/thoraxjnl-2018-211553. Epub 2018 Apr 5.

DOI:10.1136/thoraxjnl-2018-211553
PMID:29622696
Abstract
摘要

相似文献

1
COPD and cardiovascular diseases: now is the time for action!慢性阻塞性肺疾病与心血管疾病：现在是采取行动的时候了！
Thorax. 2018 Sep;73(9):799-800. doi: 10.1136/thoraxjnl-2018-211553. Epub 2018 Apr 5.
2
Early identification of exacerbations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者病情加重的早期识别
J Prim Care Community Health. 2013 Jan;4(1):75-80. doi: 10.1177/2150131912443827. Epub 2012 Apr 18.
3
[Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].[2007年波兰多中心研究中慢性阻塞性肺疾病加重期在初级和二级医疗保健中的费用]
Pol Merkur Lekarski. 2009 Mar;26(153):208-14.
4
[Chronic obstructive pulmonary disease and cardiovascular diseases].[慢性阻塞性肺疾病与心血管疾病]
Pneumonol Alergol Pol. 2010;78(1):28-32.
5
Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病恶化期的心脏功能障碍。
Lancet Respir Med. 2016 Feb;4(2):138-48. doi: 10.1016/S2213-2600(15)00509-3. Epub 2016 Jan 16.
6
Preclinical murine models of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的临床前小鼠模型。
Eur J Pharmacol. 2015 Jul 15;759:265-71. doi: 10.1016/j.ejphar.2015.03.029. Epub 2015 Mar 24.
7
Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.气流受限疾病患者在基层医疗环境中的病情加重情况及医疗资源利用：PUMA研究
Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3059-3067. doi: 10.2147/COPD.S120776. eCollection 2016.
8
Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease.慢性阻塞性肺疾病患者的初级保健——第4部分：了解一种进行性疾病的临床表现
Am J Med. 2008 Jul;121(7 Suppl):S33-45. doi: 10.1016/j.amjmed.2008.04.005.
9
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
10
Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重期呼吸道病毒感染的患病率及危险因素
Tohoku J Exp Med. 2016 Oct;240(2):131-139. doi: 10.1620/tjem.240.131.

引用本文的文献

1
Cardiovascular Health Metrics, Genetic Susceptibility, and Incident Chronic Obstructive Pulmonary Disease: A Prospective Cohort Analysis.心血管健康指标、遗传易感性与慢性阻塞性肺疾病的发病：一项前瞻性队列分析
JACC Adv. 2025 Jul 16;4(8):102003. doi: 10.1016/j.jacadv.2025.102003.
2
Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications.支气管扩张-慢性阻塞性肺疾病重叠综合征：其病理生理学及潜在心血管影响的综合综述
Ther Adv Pulm Crit Care Med. 2024 Dec 9;19:29768675241300808. doi: 10.1177/29768675241300808. eCollection 2024 Jan-Dec.
3
Systemic Manifestations of COPD and the Impact of Dual Bronchodilation with Tiotropium/Olodaterol on Cardiac Function and Autonomic Integrity.
慢性阻塞性肺疾病的全身表现以及噻托溴铵/奥达特罗双重支气管扩张对心脏功能和自主神经完整性的影响。
J Clin Med. 2024 May 16;13(10):2937. doi: 10.3390/jcm13102937.
4
Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema.肺气肿大鼠模型中血压升高而无内皮功能障碍。
Int J Mol Sci. 2023 Aug 9;24(16):12609. doi: 10.3390/ijms241612609.
5
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.慢性阻塞性肺疾病与心血管系统：血管修复与再生作为治疗靶点
Front Cardiovasc Med. 2021 Apr 12;8:649512. doi: 10.3389/fcvm.2021.649512. eCollection 2021.
6
Characteristics of COPD Phenotypes in Serbia.塞尔维亚 COPD 表型特征。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:643-654. doi: 10.2147/COPD.S300693. eCollection 2021.
7
The impact of the new Dutch guideline on cardiovascular risk management in patients with COPD: a retrospective study.荷兰新指南对慢性阻塞性肺疾病患者心血管风险管理的影响：一项回顾性研究。
BJGP Open. 2021 Feb 23;5(1). doi: 10.3399/bjgpopen20X101139. Print 2021 Jan.
8
Higher Blood Vascular Cell Adhesion Molecule-1 is Related to the Increased Risk of Cardiovascular Events in Chronic Obstructive Pulmonary Disease.较高的血管细胞粘附分子-1与慢性阻塞性肺疾病中心血管事件风险增加相关。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 28;15:2289-2295. doi: 10.2147/COPD.S264889. eCollection 2020.
9
Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study.英国慢性阻塞性肺疾病和心力衰竭患者的治疗充足性：历史队列研究
Pragmat Obs Res. 2020 Jun 2;11:55-66. doi: 10.2147/POR.S250451. eCollection 2020.
10
Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study.支气管扩张剂和类固醇使用对支气管扩张症-慢性阻塞性肺疾病重叠队列中心脏病和中风风险的影响：一项倾向评分匹配研究
Front Pharmacol. 2019 Nov 27;10:1409. doi: 10.3389/fphar.2019.01409. eCollection 2019.